Values are given as mean ± S.D. *♦○□ΔP<0.05; comparison within different genotypes was performed using one way Kruskal-Wallis, and then using Bonferroni post-hoc test. (□Zero risk score vs 2 risk score, Δ zero risk score vs 3 risk score, ◊zero risk score vs 4 risk score, ○zero risk score vs 5 risk score, ♦zero risk score vs 6 risk score, *zero risk score vs 7 risk score). Group 1: type 2 diabetes without nephropathy, Group 2: type 2 diabetes with nephropathy.

Figure 5: Percent change in UAE, serum creatinine and eGFR after 36 months of ACEI therapy among the seven risk scores, stratified by the presence or absence of nephropathy.